Tag: Immune modulation

While primarily known as a local anesthetic, lidocaine is increasingly recognized for its potent anti-inflammatory properties that extend beyond its pain-numbing effects. Recent clinical and preclinical studies highlight lidocaine's ability to modulate the body's immune response, suggesting it could play a significant role in managing excessive inflammation.

Chronic inflammation plays a key role in the progression of many chronic diseases, including diabetes and cardiovascular disease. For this reason, the emerging evidence suggesting that semaglutide helps with inflammation has garnered significant attention in the medical community.

In studies involving aged rats, exposure to nanomolar concentrations of the tetrapeptide Livagen significantly increased the rate of protein synthesis in liver cell cultures, almost matching the levels of young rat liver cells. This finding highlights its potential as a bioregulatory peptide, a class of short-chain amino acids investigated for their role in regulating various cellular processes.

Produced naturally by the body's innate immune system, LL-37 is the only human cathelicidin antimicrobial peptide. As a vital first-line defense molecule, the benefits of LL37 peptide are increasingly recognized for their broad-spectrum protection, wound healing properties, and ability to modulate immune responses. This makes LL-37 a promising target in regenerative and functional medicine research.

No, Ozempic is not an immunosuppressant, and evidence suggests its effect on the immune system is better described as "immune modulation" rather than suppression. While it is primarily used for type 2 diabetes and weight loss, its anti-inflammatory properties have sparked significant interest in the medical community.